COL1A1 rs1107946: Genetics and Ligament Health
The genetic variant rs1107946 is a single-nucleotide polymorphism located in the promoter region of the COL1A1 gene, historically designated as -1997G/T. It influences the transcriptional activity of type I collagen, an essential structural component of connective tissues such as tendons, ligaments, and bone. In sports genomics, researchers have explored its statistical associations with musculoskeletal soft tissue injuries, including anterior cruciate ligament (ACL) tears and tendinopathies.
What each genotype means
Typical collagen promoter activity
This genotype represents the most common form of the COL1A1 promoter region. Research into this variant is ongoing, and while some studies have explored its potential role in ligament and tendon injury susceptibility, the evidence remains limited and inconsistent across different populations. You should focus on general injury prevention strategies, as this genetic marker is not a definitive predictor of physical health outcomes.
This is the most common genotype observed in most global populations.
Varied collagen promoter activity
Carrying one copy of the T allele may influence the transcriptional activity of the COL1A1 gene, which is involved in collagen production. Some studies have investigated whether this variant contributes to differences in susceptibility to sports-related injuries, such as ACL ruptures, but findings are mixed and often limited by small sample sizes. This result should not be used to predict your personal risk of injury, as environmental and training factors play a much larger role in physical health.
This genotype is found in a significant portion of the population, with the T allele frequency typically ranging between 18% and 25% in European cohorts.
Potential altered collagen expression
This genotype involves two copies of the T allele, which has been studied for its potential influence on collagen structure and ligament integrity. While some research suggests a possible association with altered injury risk in specific athletic populations, the evidence is currently insufficient to draw firm conclusions. You should prioritize standard evidence-based injury prevention and conditioning programs, as this genetic finding is not a diagnostic tool for physical performance or injury risk.
This is the least common genotype, occurring in a smaller percentage of the population compared to the CC and CT genotypes.
What is rs1107946 and Where is It Located?
The single-nucleotide polymorphism rs1107946 is a genetic substitution located upstream in the 5-prime regulatory promoter region of the COL1A1 gene on human chromosome 17. In the sports medicine and bone literature, it is frequently referred to by its legacy promoter position as -1997G/T. Because it resides in a non-coding promoter sequence rather than within a protein-coding exon, it does not alter the primary amino acid sequence of the collagen peptide. Instead, nucleotide variations at this site can modify the binding affinity of specific transcription factors, modulating the basal rate at which the COL1A1 gene is transcribed into messenger RNA.
The Biological Function of COL1A1 and Collagen Type I
The COL1A1 gene encodes the pro-alpha-1 chain of type I collagen, which is the most abundant structural protein in the human body. Two alpha-1 chains typically assemble with one alpha-2 chain (encoded by COL1A2) to form a strong, triple-helical heterotrimer. Type I collagen fibrils provide critical tensile strength and load-bearing resilience to tendons, ligaments, joint capsules, skin, and bones. Balanced expression of collagen chains is necessary for normal fibril diameter, tissue stiffness, and biomechanical integrity. Variations that alter promoter efficiency may subtly shift collagen production, altering how connective tissues adapt to chronic mechanical stress or acute high-energy impacts.
Research Associations with Soft Tissue and Ligament Injuries
Multiple candidate-gene association studies have evaluated rs1107946 alongside adjacent COL1A1 polymorphisms, such as the functional Sp1 binding site variant rs1800012, to assess predisposition to soft tissue injuries. Researchers have observed statistical associations between rs1107946 alleles—either independently or as part of specific multi-marker promoter haplotypes—and altered susceptibility to anterior cruciate ligament (ACL) ruptures, Achilles tendon injuries, and shoulder instability. Some investigations report that carrying specific promoter alleles confers modest protective effects against acute ligament ruptures. However, the overall strength of scientific evidence remains classified as limited due to small candidate-gene cohort sizes, lack of broad genome-wide significance, and inconsistent findings across diverse populations.
Ancestry and Population Frequencies
The distribution of the alleles at rs1107946 varies meaningfully across global populations. In individuals of European descent, the minor T allele typically occurs at an estimated frequency between 18% and 22%, with the major G allele representing the majority of observed chromosomes. Global public databases like gnomAD demonstrate that allele frequencies can fluctuate substantially among other ancestries, such as African, East Asian, and admixed populations. Because linkage disequilibrium patterns between rs1107946 and adjacent regulatory sites differ substantially between ancestral backgrounds, any potential physiological impact of the variant may be context-dependent and ancestry-specific.
Translating Genetic Results: Possibilities and Limitations
It is essential to understand that rs1107946 is not a diagnostic marker and cannot predict whether an individual will experience a tendon injury or ligament tear. Musculoskeletal injuries are complex, multifactorial events determined by environmental and physical factors including training volume, neuromuscular biomechanics, fatigue, hormonal influences, playing surface, and footwear. A specific genotype at rs1107946 accounts for only a minor fraction of overall biological variation in tissue resilience. Athletes and active individuals should not use this genetic marker to alter injury rehabilitation or clinical treatments, but instead rely on evidence-based conditioning, balanced strength training, and appropriate rest protocols.
How common is this variant?
The minor T allele frequency is approximately 0.18 to 0.22 in European populations, while the ancestral G allele represents the predominant allele globally across reference populations in gnomAD.
Frequently asked questions
Can testing rs1107946 determine if I will tear my ACL?
No, this genetic test cannot diagnose or predict whether you will experience an ACL tear. Ligament ruptures depend primarily on biomechanical forces, physical conditioning, sports participation, and environmental circumstances. The variant is merely a statistical association in population-level studies.
Does having a specific rs1107946 genotype mean I need collagen supplements?
No direct clinical evidence supports targeted collagen supplementation based on your rs1107946 genotype. Collagen synthesis relies on balanced nutrition and appropriate mechanical stimulus rather than genotype-guided supplementation. Consult a registered dietitian or physician before starting any dietary supplement regimen.
What is the difference between rs1107946 and -1997G/T?
They refer to the exact same genetic variation. The code rs1107946 is the standardized dbSNP reference identifier, whereas -1997G/T is a traditional designation denoting the variant's position 1,997 base pairs upstream of the COL1A1 transcription start site.
Should athletes adjust their training based on this variant?
No, athletes should not modify their training solely based on genetic results from rs1107946. Established neuromuscular warm-up programs, proper conditioning, and adequate recovery periods provide proven injury reduction benefits regardless of individual genetic variations.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1107946?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in COL1A1
This SNP is linked to an age-protective methylation marker in collagen genes, influencing perceived facial aging.
The Sp1 binding site polymorphism in COL1A1 has been extensively studied for associations with bone mineral density (BMD) and fracture risk, though results remain inconsistent across different populations.
An intronic Sp1 transcription factor binding-site variant (often termed the +1245 G/T or Sp1 polymorphism) that influences type I collagen alpha-1 chain synthesis, impacting tendon elasticity, cruciate ligament tear risk, and bone mineral density under mechanical loading.
Regulates Sp1 binding affinity within the COL1A1 regulatory promoter, modulating baseline bone mineral density and connective tissue flexibility traits.
Intronic collagen type I alpha 1 variant associated with cruciate ligament rupture risk and tendon tensile stiffness in sports performance.
Variant in COL1A1 linked to dermal matrix elasticity, skin thickness, and vulnerability to dermal wrinkle formation.